Cargando…
Economic Evaluation of Cardio inCode(®), a Clinical-Genetic Function for Coronary Heart Disease Risk Assessment
BACKGROUND: A clinical–genetic function (Cardio inCode(®)) was generated using genetic variants associated with coronary heart disease (CHD), but not with classical CHD risk factors, to achieve a more precise estimation of the CHD risk of individuals by incorporating genetics into risk equations [Fr...
Autores principales: | Ramírez de Arellano, A., Coca, A., de la Figuera, M., Rubio-Terrés, C., Rubio-Rodríguez, D., Gracia, A., Boldeanu, A., Puig-Gilberte, J., Salas, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825137/ https://www.ncbi.nlm.nih.gov/pubmed/24078223 http://dx.doi.org/10.1007/s40258-013-0053-x |
Ejemplares similares
-
Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism
por: Rubio-Terrés, C., et al.
Publicado: (2015) -
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain
por: Casado, Luis Felipe, et al.
Publicado: (2016) -
Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain
por: Rubio-Terrés, Carlos, et al.
Publicado: (2016) -
CardioMEMS: the next revolution in heart failure management?
por: Handoko, M. L., et al.
Publicado: (2019) -
Análisis coste-utilidad de apixabán frente al ácido acetilsalicílico en la prevención del ictus en pacientes con fibrilación auricular no valvular en España
por: Escolar-Albaladejo, Ginés, et al.
Publicado: (2016)